PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
41.41%
Net income growth at 50-75% of ORCL's 64.28%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
4.11%
Less D&A growth vs. ORCL's 9.74%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-28.72%
Negative yoy working capital usage while ORCL is 131.40%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-58.51%
Negative yoy usage while ORCL is 131.40%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
No Data
No Data available this quarter, please select a different quarter.
19.39%
Operating cash flow growth below 50% of ORCL's 56.74%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-26.09%
Negative yoy CapEx while ORCL is 29.65%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-146.15%
Both yoy lines negative, with ORCL at -167.86%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-16.23%
We reduce yoy invests while ORCL stands at 4.36%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-12.84%
Negative yoy issuance while ORCL is 374.29%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
74.83%
We have some buyback growth while ORCL is negative at -3.87%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.